A highly sensitive blood test can detect signs of pancreatic cancer that standard methods often miss, according to results of ...

Charles River Laboratories International (CRL) has drawn fresh investor attention after announcing a collaboration with ...

Plasmid errors are more common than most researchers expect, and can result in consequences such as failed cloning, irreproducible results, and wasted time and resources. Yet many labs still rely on ...

By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing machine on Monday, marking a bid by the Swiss drugmaker and diagnostics ...

Imagine visiting a doctor and receiving treatment designed not only for your condition, but for your unique genetic and ...

The first era of AI was about access to knowledge. The second was about generating digital work. The next will be about ...

More than 200 leaders from academia, biotechnology, venture capital, and patient advocacy gathered at the Yale Club of New York City for the inaugural America's Got Research (AGR). The ...

Alexander Spira, MD, PhD, FACP, FASCO, explains why sarcoma treatment lags behind other solid tumors and the access, subtype, and biomarker barriers. Spira: There are a couple of reasons why. First of ...

Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.

Sulfoxaflor, a pesticide the U.S. Environmental Protection Agency approved for long-term agricultural use with what it called ...

Jorge Garces, who joined Abbott to oversee scientific strategy for cancer diagnostics after it acquired Exact Sciences, ...

Roth vs. Traditional is a tax‑timing decision: pay tax now or later. Roth suits low‑bracket earners; Traditional helps ...